Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
View Scopus Profile
Bo Zhou, PhD
Assistant Professor
,
Pharmacotherapy
UNT System College of Pharmacy
Email
Bo.Zhou
unthsc
edu
h-index
92
Citations
4
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2021
2026
Research activity per year
Overview
Fingerprint
Network
Sponsored Projects
(4)
Publications
(10)
Similar Profiles
(5)
Fingerprint
Dive into the research topics where Bo Zhou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Medicare Beneficiaries
100%
United States
83%
Opioids
62%
Cost Sharing
62%
Co-payment
62%
Medicare Part D
43%
Retrospective Cohort Analysis
40%
Non-vitamin K Antagonist Oral Anticoagulants
31%
Formulary Restriction
31%
Switching Costs
31%
Inertia
31%
Exenatide
31%
Adrenergic Receptor Agonists
31%
Alzheimer's Disease
31%
Parkinson's Disease
31%
Atrial Fibrillation
31%
Stroke Risk
31%
Health Insurance Marketplace
31%
MiR-223
31%
Radium-223
31%
Utilization Pattern
31%
SEER-Medicare
31%
Working Adults
31%
Inflation
31%
Long-term Trends
31%
Affordable Care Act
31%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
31%
Older Men
31%
Treatment Landscape
31%
High Cost
27%
Confidence Interval
26%
Adjusted Odds Ratio
26%
Type 2 Diabetes Mellitus (T2DM)
24%
Survey Data
23%
Social Determinants of Health (SDoH)
23%
Disease Onset
20%
Asthma
20%
Individual Mandate
20%
National Health Interview Survey
20%
Opioid Use
20%
Risk Reduction
16%
Odds Ratio
16%
Comorbidity
16%
Anticoagulant Use
15%
Plan Selection
14%
Clawback Provisions
13%
Prescription Opioid Misuse
13%
5-cycle
13%
Repeated Cross-sectional Survey
13%
Instrumental Variable Method
13%
Medicine and Dentistry
Glucagon-Like Peptide-1 Agonist
62%
Diabetes
62%
Medicare
58%
Atrial Fibrillation
31%
Apoplexy
31%
Antithrombotic
31%
Prostate Cancer
31%
Exenatide
31%
Alzheimer's Disease
31%
Type 2 Diabetes
24%
Cohort Analysis
16%
Health Outcomes
13%
Insulin Sensitizing Agent
12%
Castration Resistant Prostate Cancer
12%
Proportional Hazards Model
10%
Primary Outcome
10%
Health Care
10%
Transient Ischemic Attack
8%
Cancer Therapy
6%
Logistic Regression Analysis
6%
Instrumental Variable Analysis
6%
Cancer Registry
6%
Odds Ratio
6%
Overall Survival
6%
Oncology
6%
Maturity Onset Diabetes of the Young
6%
Comorbidity
6%
Clinician
6%
Mopidamol
6%
Glucagon Like Peptide 1
5%
Hypoglycemia
5%
Prescription Medication
5%
Health Care Cost
5%
Social Determinants of Health
5%
Physical Activity
5%
